AI assistant
Sending…
GENTEX CORP — Director's Dealing 2021
Nov 3, 2021
30893_dirs_2021-11-03_46a75213-923b-425b-95f7-8e1eb65513d2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2021-11-03
Reporting Person: Wallace James H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-03 | Common Stock | M | 7000.00 | $15.74 | Acquired | 35709.00 | Direct |
| 2021-11-03 | Common Stock | S | 7000.00 | $36.2347 | Disposed | 28709.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-03 | Non-Employee Director Stock Option Grant | $15.74 | M | 7000.00 | Disposed | 2026-05-19 | Common Stock (7000.00) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $36.15 to $36.30. The price reported above reflects the weighted average price.
More from GENTEX CORP
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19